Sign in
4

Changes in Ownership

NEOGENOMICS INC Filed Acc 0001077183-24-000028

Options or other derivatives

  • Chief Executive Officer acquired 632,419 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Smith Christopher M · Chief Executive Officer

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2024-02-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +287,940 287,940 D
2024-02-23 Grant or award : show line 2 in the form Restricted Stock Unit +172,239 172,239 D
2024-02-23 Grant or award : show line 3 in the form Performance Stock Unit +172,240 172,240 D
Loading xslF345X05/wk-form4_1709069286.xml…